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SF-36 had acceptable reliability of Cronbach alpha values of 0.7. CONCLUSIONS:
Patients on kidney transplant waiting list had worse HRQoL than the general pop-
ulation. More research could be done into reasons for poorer HRQoL among the
at-risk patients. SF-36 was a reliable tool in assessing the HRQoL of patients on
kidney transplant waiting list in Singapore.
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OBJECTIVES: There is a lack of a psychometrically robust bariatric-specific health
related quality of life (HRQOL) tool. A mono-centric prospective study was con-
ducted to develop and validate a new bariatric specific 81-item self report HRQOL
instrument called the Bariatric and Obesity Surgery Survey (BOSS). METHODS:
Data were collected from 236 participants: 83 patients who were under consider-
ation for bariatric surgery, 68 patients who already have had a bariatric procedure
and 85 volunteers. Participants were also required to complete the Short Form
Health survey (SF-36), Hospital Anxiety and Depression (HADS) scale, Moorehead-
Ardelt Quality of life Questionnaire (M-A QoLQ II), and a demographic data sheet.
Two weeks following the completion of these 5 questionnaires, participants were
asked to complete BOSS once more along with a feedback sheet. RESULTS: Explor-
atory factor analysis revealed a multidimensional instrument consisting of 42
items distributed over 6 domains that address various HRQOL aspects and dimen-
sions pertinent to bariatric surgery, and relevant to morbidly obese patients. Fur-
ther psychometric analysis showed that BOSS has adequate internal consistency
reliability (Cronbach   0.970), test re-test reliability (ICC  0.926), construct va-
lidity, criterion validity, face validity and acceptability. CONCLUSIONS: BOSS is a
valid and reliable multidimensional instrument that provides a clinically useful
and relevant measure to assess HRQoL in patients undergoing bariatric surgery.
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OBJECTIVES: To compare the incidence of post-operative complications, health-
care utilization, and costs in laparoscopic supracervical hysterectomy (LSH) versus
laparoscopic-assisted vaginal hysterectomy (LAVH) patients. METHODS: Women
18 years with LSH or LAVH from 1/1/2007 - 9/30/ 2008 were identified in the
Thomson Reuters MarketScan® Commercial Claims and Encounter Database. Pa-
tients were required to have 6 months of continuous medical and prescription
coverage prior and subsequent to the hysterectomy date. Patients were excluded if
they had a diagnosis of cancer, had index date procedure codes for both LSH and
LAVH, or if the length of stay associated with the index procedure exceeded 20
days. Post-operative outcomes and gynecologic-related (GYN-related) utilization
and costs were measured 30 and 180 days post-surgery. Multivariate analysis was
conducted to compare post-surgical outcomes and costs between patients with
LSH and LAVH controlling for demographic and clinical characteristics. RESULTS:
A total of 6,198 LSH patients and 14,181 LAVH patients met the study criteria.
Compared with the LAVH cohort, LSH patients were more likely to have dysfunc-
tional uterine bleeding (32.6% vs. 27.9%) and leiomyomas (38.0% vs. 26.3%) as their
primary diagnosis and less likely to have endometriosis (9.3% vs. 10.4%) and pro-
lapse (1.5% vs. 8.0%), p0.01 in all cases; had significantly lower overall infection
rates (6.2% vs. 7.4%, p0.002); and had significantly lower total GYN-related costs
($252 vs. $385, p0.001, 30 days post-surgery; $350 vs. $569, p0.001, 180 days post-
surgery). After multivariate adjustment for patient characteristics, total costs were
estimated to be $108 and $174 lower for LSHpatients than for LAVHpatientswithin 30
and 180 days of follow up, respectively (p0.001). LSH patients had significantly lower
hazards of developing infection (hazard ratio [HR]0.830), hematologic complication
(HR0.667), and analgesic use (HR0.812). CONCLUSIONS: LSH patients demon-
strated fewer post-operative infections and lower GYN-related costs compared to
LAVH patients.
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OBJECTIVES: To examine the variation in outlier payments across U.S. hospitals
and the extent to which the variation is explained by patient and hospital factors,
including quality of care.METHODS:Using the National Medicare Claims database
for 2002, we examined outlier payments in patients undergoing coronary artery
bypass grafting (CABG) (n165,226), lower extremity bypass surgery (n43,886) and
colectomy (n101,345). We then categorized hospitals performing these proce-
dures according to their outlier payment rates. Using multiple logistic regression,
we explored the relationships between hospital outlier payment rates, patient case
mix and hospital quality, as reflected by risk-adjusted mortality rates. RESULTS:
For all three procedures, the proportion of patients associated with outlier pay-
ments varied from 10% (colectomy) to 14% (CABG). Average outlier payments were
considerable, ranging from$18,000 to over $24,000 per patient. Themost consistent
risk factors for outlier payments included race and admission acuity. Higher hos-
pital and surgeon volumes and teaching status were associated with lower rates of
outlier payments. There was a negative correlation between risk-adjusted mortal-
ity rates and outlier payments. For all three procedures, the proportion of outlier
payments varied widely across hospitals from less than 5% to greater than 20%.
Measurable patient and hospital factors explained a small proportion of variation
across hospitals.CONCLUSIONS:Outlier payments are an important component of
medical costs for inpatient surgery. Although explained in part by quality, the
reasons for a wide variation in outlier payments across hospitals remain to be
clarified.
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OBJECTIVES: 1. Examine the impact of insurance on treatment of localized
breast cancer using Breast Conserving Surgery (BCS) with radiation. 2. Identify
factors that contribute to women’s receiving breast conserving surgery with
radiation. METHODS: Breast cancer cases diagnosed during 1997-2002 were ob-
tained from the Florida Cancer Data System. Women aged 40 and above with lo-
calized breast cancer were included. Demographic, insurance, and treatment in-
formation were extracted and linked with 2000 Census data to get tract-level
information on education and poverty level. Multi-level logistic regression analysis
was conducted to determine factors that have contributed to BCS with radiation
treatment.RESULTS: 41,508womenwere diagnosedwith localized breast cancer in
Florida during 1997-2002. The study found that BCS without radiation andmastec-
tomywere the twomajor treatments for localized breast cancer. The average age of
the women was 66 years with 8.5% of them receiving BCS with radiation. Women
with the following characteristics were more likely to receive BCS with radiation
than their counterparts: having private or Medicare insurance, being married, liv-
ing in neighborhood with higher percentage of high school education, and being
recently diagnosed. CONCLUSIONS: Although BCS with radiation is recommended
to treat women with localized breast cancer by clinical practice guidelines and the
use of this treatment has significantly increased over time, there are still differ-
ences in receiving the treatment among women with different health insurance
and marital status. Possible reasons for the differences require further research.
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OBJECTIVES: To assess the pattern of radiotherapy and radiosurgery for newly
diagnosed and recurred brain metastasis. METHODS: Using the Korean Health
Insurance Review&Assessment Service (HIRA) claims database, patientswho aged
20 or more, diagnosed as brain metastasis (ICD 10 C79.3) during January 1st, 2006
and June 30th, 2008, treated whole brain radiotherapy (WBRT) or stereotactic ra-
diosurgery (SRS), and without history of brain metastasis diagnosis or treatment
within 6months prior to index treatmentwere identified.With a permissible gap of
30 days, each treatment episodes were defined. The episodes were categorized as
those for newly diagnosed and recurrent brainmetastasis patients. Characteristics
of patients, frequency of WBRT/ SRS as initial and recurrence treatment, and the
mean number of re-treatment were analyzed. RESULTS: A total of 7,449 newly
treated patients and 2,008 recurrent patients satisfied the selection criteria. Among
new patients, 4,797 (64.4%) treated WBRT, 1,439 (19.3%) treated SRS, and 1,213
(16.3%) treated WBRT with SRS. Most frequent primary tumor was lung cancer
(57.2%). Recurrence rate of the new patients was 27.0%. Mean number of re-treat-
ment of WBRT or SRS was 1.38. Among patients who treated WBRT and SRS as
initial treatments, 69.8% and 50.2% treated the same treatment as first treatment
for recurrence, respectively. CONCLUSIONS: While clinical guidelines for brain
metastasis recommends WBRT with SRS for brain metastasis patients with favor-
able functional status, the proportion ofWBRTwith SRSwas relatively low. Further
research to explore the reason of the gap between evidence and real practice is
needed.
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OBJECTIVES: Observational study is difficult to interpret due to a number of meth-
odological issues; cohort effects, the learning curve of the health care provider and
confounding by indication: This large scale retrospective study is aimed to ascer-
tain that there are indication bias of LASIK surgery between local hospital and
tertiary hospital in South Korea.METHODS: A retrospective cohort for consecutive
3,401 eyes received LASIK in 6 multicenter including tertiary hospital and local
hospital from 2002 to 2005 were registered. Sociodemographic, operation charac-
teristics, preoperative baseline manifest refractions (MR) and additional follow up
data at 3month, 6month and 12 month after surgery were collected. We used
independent t-test to compare preoperative difference between tertiary hospital
and local hospital and generalized linear mixed model with random intercept to
test characteristic of hospital and follow up time might influence to MR after
surgery. RESULTS:The baselineMR (meanSD) of tertiary hospital was5.242.07
and that of local hospital was 4.271.71 (p0.001). The mean MR at 3 month, 6
month and 12 month of tertiary hospital were 0.460.70, 0.550.69 and
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